Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases

Saved in:
Bibliographic Details
Published in:The Journal of infection 2022-02, Vol.84 (2), p.e22-e23
Main Authors: Manolache, Narcis-George, Ursachi, Vasile, Scohy, Anaïs, Desmet, Charlotte, Yombi, Jean Cyr, Nzeusseu Toukap, Adrien, Stoenoiu, Maria Simona
Format: Article
Language:English
Subjects:
Antibodies, Viral
Antibody Formation
COVID-19
Humans
IMID
Letter to the Editor
Methotrexate
mRNA vaccine
Psoriatic arthritis
Rheumatic disease
Rheumatic Diseases
Rheumatoid arthritis
SARS-CoV-2
Spondyloarthritis
Vaccination
Viral vector vaccine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c455t-24d0b724746153b24c4bc100fa3e6bfbdc3316ef86d151315c7d62670c4cc8c23
cites cdi_FETCH-LOGICAL-c455t-24d0b724746153b24c4bc100fa3e6bfbdc3316ef86d151315c7d62670c4cc8c23
container_end_page e23
container_issue 2
container_start_page e22
container_title The Journal of infection
container_volume 84
creator Manolache, Narcis-George
Ursachi, Vasile
Scohy, Anaïs
Desmet, Charlotte
Yombi, Jean Cyr
Nzeusseu Toukap, Adrien
Stoenoiu, Maria Simona
description
doi_str_mv 10.1016/j.jinf.2021.12.006
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8673932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0163445321005971</els_id><sourcerecordid>2611658573</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-24d0b724746153b24c4bc100fa3e6bfbdc3316ef86d151315c7d62670c4cc8c23</originalsourceid><addsrcrecordid>eNp9kU1vEzEQhi1ERdPCH-CAfOSyi7_Wm0gIKYqAIlWqRIGr5R3PEkeJHWxvUP89DilVe-E0HvuZd8bzEvKas5Yzrt9t2o0PYyuY4C0XLWP6GZnxTopG9Eo8J7MKyUapTp6Ti5w3jLGFXOgX5FyqhWBMqBkxy1IwTLagozYU39wuv942q_ijEX_zIbo7mjDvY8hIS6QHC-CDLT4G6gPd1xOGkulvX9Y0rXHa1Rugzme0GfNLcjbabcZX9_GSfP_08dvqqrm--fxltbxuQHVdaYRybOiF6pWuHxiEAjUAZ2y0EvUwDg6k5BrHuXa845J30DstdM9AAcxByEvy4aS7n4YdOqgzJbs1--R3Nt2ZaL15-hL82vyMBzPXvVzIo8Dbe4EUf02Yi9n5DLjd2oBxykZoznU373pZUXFCIcWcE44PbTgzR2fMxhydMUdnDBemOlOL3jwe8KHknxUVeH8CsK7p4DGZDHW1gM4nhGJc9P_T_wP2OaDb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2611658573</pqid></control><display><type>article</type><title>Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases</title><source>ScienceDirect Freedom Collection</source><creator>Manolache, Narcis-George ; Ursachi, Vasile ; Scohy, Anaïs ; Desmet, Charlotte ; Yombi, Jean Cyr ; Nzeusseu Toukap, Adrien ; Stoenoiu, Maria Simona</creator><creatorcontrib>Manolache, Narcis-George ; Ursachi, Vasile ; Scohy, Anaïs ; Desmet, Charlotte ; Yombi, Jean Cyr ; Nzeusseu Toukap, Adrien ; Stoenoiu, Maria Simona</creatorcontrib><identifier>ISSN: 0163-4453</identifier><identifier>EISSN: 1532-2742</identifier><identifier>DOI: 10.1016/j.jinf.2021.12.006</identifier><identifier>PMID: 34920024</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antibodies, Viral ; Antibody Formation ; COVID-19 ; Humans ; IMID ; Letter to the Editor ; Methotrexate ; mRNA vaccine ; Psoriatic arthritis ; Rheumatic disease ; Rheumatic Diseases ; Rheumatoid arthritis ; SARS-CoV-2 ; Spondyloarthritis ; Vaccination ; Viral vector vaccine</subject><ispartof>The Journal of infection, 2022-02, Vol.84 (2), p.e22-e23</ispartof><rights>2021 The British Infection Association</rights><rights>2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. 2021 The British Infection Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-24d0b724746153b24c4bc100fa3e6bfbdc3316ef86d151315c7d62670c4cc8c23</citedby><cites>FETCH-LOGICAL-c455t-24d0b724746153b24c4bc100fa3e6bfbdc3316ef86d151315c7d62670c4cc8c23</cites><orcidid>0000-0003-2107-8846 ; 0000-0003-4644-2077 ; 0000-0003-3669-1280</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34920024$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Manolache, Narcis-George</creatorcontrib><creatorcontrib>Ursachi, Vasile</creatorcontrib><creatorcontrib>Scohy, Anaïs</creatorcontrib><creatorcontrib>Desmet, Charlotte</creatorcontrib><creatorcontrib>Yombi, Jean Cyr</creatorcontrib><creatorcontrib>Nzeusseu Toukap, Adrien</creatorcontrib><creatorcontrib>Stoenoiu, Maria Simona</creatorcontrib><title>Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases</title><title>The Journal of infection</title><addtitle>J Infect</addtitle><subject>Antibodies, Viral</subject><subject>Antibody Formation</subject><subject>COVID-19</subject><subject>Humans</subject><subject>IMID</subject><subject>Letter to the Editor</subject><subject>Methotrexate</subject><subject>mRNA vaccine</subject><subject>Psoriatic arthritis</subject><subject>Rheumatic disease</subject><subject>Rheumatic Diseases</subject><subject>Rheumatoid arthritis</subject><subject>SARS-CoV-2</subject><subject>Spondyloarthritis</subject><subject>Vaccination</subject><subject>Viral vector vaccine</subject><issn>0163-4453</issn><issn>1532-2742</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kU1vEzEQhi1ERdPCH-CAfOSyi7_Wm0gIKYqAIlWqRIGr5R3PEkeJHWxvUP89DilVe-E0HvuZd8bzEvKas5Yzrt9t2o0PYyuY4C0XLWP6GZnxTopG9Eo8J7MKyUapTp6Ti5w3jLGFXOgX5FyqhWBMqBkxy1IwTLagozYU39wuv942q_ijEX_zIbo7mjDvY8hIS6QHC-CDLT4G6gPd1xOGkulvX9Y0rXHa1Rugzme0GfNLcjbabcZX9_GSfP_08dvqqrm--fxltbxuQHVdaYRybOiF6pWuHxiEAjUAZ2y0EvUwDg6k5BrHuXa845J30DstdM9AAcxByEvy4aS7n4YdOqgzJbs1--R3Nt2ZaL15-hL82vyMBzPXvVzIo8Dbe4EUf02Yi9n5DLjd2oBxykZoznU373pZUXFCIcWcE44PbTgzR2fMxhydMUdnDBemOlOL3jwe8KHknxUVeH8CsK7p4DGZDHW1gM4nhGJc9P_T_wP2OaDb</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Manolache, Narcis-George</creator><creator>Ursachi, Vasile</creator><creator>Scohy, Anaïs</creator><creator>Desmet, Charlotte</creator><creator>Yombi, Jean Cyr</creator><creator>Nzeusseu Toukap, Adrien</creator><creator>Stoenoiu, Maria Simona</creator><general>Elsevier Ltd</general><general>The British Infection Association. Published by Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2107-8846</orcidid><orcidid>https://orcid.org/0000-0003-4644-2077</orcidid><orcidid>https://orcid.org/0000-0003-3669-1280</orcidid></search><sort><creationdate>20220201</creationdate><title>Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases</title><author>Manolache, Narcis-George ; Ursachi, Vasile ; Scohy, Anaïs ; Desmet, Charlotte ; Yombi, Jean Cyr ; Nzeusseu Toukap, Adrien ; Stoenoiu, Maria Simona</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-24d0b724746153b24c4bc100fa3e6bfbdc3316ef86d151315c7d62670c4cc8c23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies, Viral</topic><topic>Antibody Formation</topic><topic>COVID-19</topic><topic>Humans</topic><topic>IMID</topic><topic>Letter to the Editor</topic><topic>Methotrexate</topic><topic>mRNA vaccine</topic><topic>Psoriatic arthritis</topic><topic>Rheumatic disease</topic><topic>Rheumatic Diseases</topic><topic>Rheumatoid arthritis</topic><topic>SARS-CoV-2</topic><topic>Spondyloarthritis</topic><topic>Vaccination</topic><topic>Viral vector vaccine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Manolache, Narcis-George</creatorcontrib><creatorcontrib>Ursachi, Vasile</creatorcontrib><creatorcontrib>Scohy, Anaïs</creatorcontrib><creatorcontrib>Desmet, Charlotte</creatorcontrib><creatorcontrib>Yombi, Jean Cyr</creatorcontrib><creatorcontrib>Nzeusseu Toukap, Adrien</creatorcontrib><creatorcontrib>Stoenoiu, Maria Simona</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Manolache, Narcis-George</au><au>Ursachi, Vasile</au><au>Scohy, Anaïs</au><au>Desmet, Charlotte</au><au>Yombi, Jean Cyr</au><au>Nzeusseu Toukap, Adrien</au><au>Stoenoiu, Maria Simona</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases</atitle><jtitle>The Journal of infection</jtitle><addtitle>J Infect</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>84</volume><issue>2</issue><spage>e22</spage><epage>e23</epage><pages>e22-e23</pages><issn>0163-4453</issn><eissn>1532-2742</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34920024</pmid><doi>10.1016/j.jinf.2021.12.006</doi><orcidid>https://orcid.org/0000-0003-2107-8846</orcidid><orcidid>https://orcid.org/0000-0003-4644-2077</orcidid><orcidid>https://orcid.org/0000-0003-3669-1280</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0163-4453
ispartof The Journal of infection, 2022-02, Vol.84 (2), p.e22-e23
issn 0163-4453
1532-2742
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8673932
source ScienceDirect Freedom Collection
subjects Antibodies, Viral
Antibody Formation
COVID-19
Humans
IMID
Letter to the Editor
Methotrexate
mRNA vaccine
Psoriatic arthritis
Rheumatic disease
Rheumatic Diseases
Rheumatoid arthritis
SARS-CoV-2
Spondyloarthritis
Vaccination
Viral vector vaccine
title Attenuated anti-SARS-CoV-2 antibody response to vaccination in patients with rheumatic diseases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T22%3A08%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Attenuated%20anti-SARS-CoV-2%20antibody%20response%20to%20vaccination%20in%20patients%20with%20rheumatic%20diseases&rft.jtitle=The%20Journal%20of%20infection&rft.au=Manolache,%20Narcis-George&rft.date=2022-02-01&rft.volume=84&rft.issue=2&rft.spage=e22&rft.epage=e23&rft.pages=e22-e23&rft.issn=0163-4453&rft.eissn=1532-2742&rft_id=info:doi/10.1016/j.jinf.2021.12.006&rft_dat=%3Cproquest_pubme%3E2611658573%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-24d0b724746153b24c4bc100fa3e6bfbdc3316ef86d151315c7d62670c4cc8c23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2611658573&rft_id=info:pmid/34920024&rfr_iscdi=true